(2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl]amino]pentanamide → HCID 11613537, compound
Reaction equation
Br[C:2]1[S:3][CH:4]=[C:5]([C:7]2([C:10]([O:12]CC)=[O:11])[CH2:9][CH2:8]2)[N:6]=1.[C:15]([C:17]1([NH:20][C:21](=[O:49])[C@H:22]([CH2:44][C:45]([F:48])([CH3:47])[CH3:46])[NH:23][C@@H:24]([C:29]2[CH:34]=[CH:33][C:32](B3OC(C)(C)C(C)(C)O3)=[CH:31][CH:30]=2)[C:25]([F:28])([F:27])[F:26])[CH2:19][CH2:18]1)#[N:16]>CN(C=O)C.C([O-])([O-])=O.[Na+].[Na+].C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[C:15]([C:17]1([NH:20][C:21]([C@@H:22]([NH:23][C@@H:24]([C:29]2[CH:30]=[CH:31][C:32]([C:2]3[S:3][CH:4]=[C:5]([C:7]4([C:10]([OH:12])=[O:11])[CH2:8][CH2:9]4)[N:6]=3)=[CH:33][CH:34]=2)[C:25]([F:26])([F:28])[F:27])[CH2:44][C:45]([F:48])([CH3:47])[CH3:46])=[O:49])[CH2:19][CH2:18]1)#[N:16]Participants
6
Reactant 2
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 80 °C
Procedure
A solution of ethyl 1-(2-bromo-1,3-thiazol-4-yl)cyclopropanecarboxylate (166 mg, 1.2 mmol) and N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethyl}-L-leucinamide (Example 3, Step 3, 250 mg, 0.5 mmol) in DMF (5 mL) and 2M Na2CO3 (0.63 mL) was degassed with a stream of nitrogen for 10 min, then PdCl2(dppf) (41 mg 0.05 mmol) was added and the mixture heated to 80° C. for 8 h. The mixture was cooled and partitioned between ethyl acetate and saturated aqueous ammonium chloride. The organic phase was washed with brine, dried over MgSO4 and evaporated. Purification by SiO2 chromatography (30% ethyl acetate/hexanes) provided the title compound.
Workup
- temperatureThe mixture was cooled
- custompartitioned between ethyl acetate and saturated aqueous ammonium chloride
- washThe organic phase was washed with brine
- dry with materialdried over MgSO4
- customevaporated
- customPurification by SiO2 chromatography (30% ethyl acetate/hexanes)
Sources & evidence
- ORD record
- ord-b6aad4ee123f45de81cc4ec1ab343d4a
- Source dataset
- uspto-grants-2007_12
- Patent number
- US07312353B2
Reaction notes
Loading…